Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tsukasa Hasegawa
Observed names:
Hasegawa, Tsukasa,
TSUKASA HASEGAWA
Institutions:
Jikei University School of Medicine,
The Jikei University West Medical Center
Observed institutions:
Jikei University School of Medicine,
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research,
Atsugi City Hospital,
The Jikei University West Medical Center
ORCID:
0000-0001-8385-9416
Observed ORCID:
0000-0001-8385-9416
OpenAlex ID:
A5006479281
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors
2020
·
Takehiro Tozuka
, Satoru Kitazono
, et al.
·
BMC Cancer
·
47
PDF
Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer
2019
·
TSUKASA HASEGAWA
, NORIKO YANAGITANI
, et al.
·
Anticancer Research
·
41
PDF
Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment
2020
·
Takehiro Tozuka
, Satoru Kitazono
, et al.
·
Lung Cancer
·
38
Predictive factors for relapse of cryptogenic organizing pneumonia
2019
·
Zenya Saito
, Yugo Kaneko
, et al.
·
BMC Pulmonary Medicine
·
37
PDF
Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases
2020
·
Takehiro Tozuka
, Satoru Kitazono
, et al.
·
Thoracic Cancer
·
19
PDF
Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02)
2023
·
Tsukasa Hasegawa
, Ryo Ariyasu
, et al.
·
Cancer Chemotherapy and Pharmacology
·
15
Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer
2020
·
TSUKASA HASEGAWA
, NORIKO YANAGITANI
, et al.
·
In Vivo
·
15
PDF
Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease
2022
·
Naoki Takasaka
, Yusuke Hosaka
, et al.
·
Respiratory Medicine
·
10
Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC
2019
·
Yoshiaki Amino
, Satoru Kitazono
, et al.
·
International Journal of Clinical Oncology
·
10
Comparison of immune checkpoint inhibitor plus chemotherapy or ipilimumab plus nivolumab-based therapy for NSCLC patients with PD-L1 TPS (1–49 %): TOPGAN2023-01
2024
·
Hisashi Tanaka
, Tomonori Makiguchi
, et al.
·
European Journal of Cancer
·
8
PDF
Neutropenia related to an azathioprine metabolic disorder induced by an inosine triphosphate pyrophosphohydrolase (ITPA) gene mutation in a patient with PR3-ANCA-positive microscopic polyangiitis
2018
·
Kosuke Honda
, Akimitsu Kobayashi
, et al.
·
Clinical Nephrology
·
7
Association between the extent of intrapulmonary spread on chest CT and false-negative results of T-SPOT.TB in pulmonary tuberculosis: a retrospective study
2025
·
Ryo Sato
, Naoki Takasaka
, et al.
·
BMC Infectious Diseases
·
6
Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts
2020
·
Zenya Saito
, Masahiro Yoshida
, et al.
·
Lung
·
6
Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patients
2020
·
Takehiro Tozuka
, Noriko Yanagitani
, et al.
·
Cancer Treatment and Research Communications
·
6
PDF
Mild Lung Tuberculosis in a Patient Suffering from Status Epilepticus Caused by the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH)
2017
·
Mitsuo Hashimoto
, Saki Kuriiwa
, et al.
·
Internal Medicine
·
4
PDF
Association between serum ferritin level and decreased diffusion capacity 3 months after the onset of COVID-19 pneumonia
2023
·
Kyota Shinfuku
, Naoki Takasaka
, et al.
·
PLoS ONE
·
2
PDF
Allergic bronchopulmonary aspergillosis in a patient with ankylosing spondylitis treated with adalimumab
2021
·
Yudai Suzuki
, Naoki Takasaka
, et al.
·
Respirology Case Reports
·
2
PDF
Infective endocarditis due to nasal septal perforation during home oxygen therapy
2024
·
Kyota Shinfuku
, Naoki Takasaka
, et al.
·
Respirology Case Reports
·
1
PDF
Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer
2020
·
Tsukasa Hasegawa
, Noriko Yanagitani
, et al.
·
International Journal of Clinical Oncology
·
1
Efficacy of ipilimumab plus nivolumab with or without chemotherapy according to baseline tumor size: a multicenter retrospective study
2026
·
Hisashi Tanaka
, Tomonori Makiguchi
, et al.
·
Translational Lung Cancer Research
未治療非小細胞肺癌における抗pd-1/l1抗体+プラチナ製剤併用療法に抗ctla-4抗体の上乗せによる安全性と有効性の検討 (第133回成医会第三支部例会)
2025
·
Hasegawa, Tsukasa
, Sato, Ryo
, et al.
·
Institutional Repositories DataBase (IRDB)
PDF
Comparison of ICI plus chemotherapy or ipilimumab plus nivolumab based therapy for patients with NSCLC with TPS (1-49%): TOPGAN2023-01.
2024
·
Takehiro Tozuka
, Hisashi Tanaka
, et al.
·
Journal of Clinical Oncology
PDF
Ultrasonic humidifier lung with a reversed halo sign: A case report
2024
·
Tsukasa Hasegawa
, Kai Ryu
, et al.
·
Radiology Case Reports
未治療進展型小細胞肺癌におけるプラチナ製剤併用療法とpd-l1阻害薬の有効性と安全性の検討 (第128回成医会第三支部例会)
2021
·
Hasegawa, Tsukasa
, 千田, 健太郎
, et al.
·
Institutional Repositories DataBase (IRDB)
PDF
Efficacy of anti-programmed cell death-1/ligand 1 monotherapy for non-small cell lung cancer patients with active brain metastases.
2020
·
Takehiro Tozuka
, Satoru Kitazono
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
26
Citation count:
275
H-index:
9
I10-index:
9
Year
Topic
Type